# Prelude Therapeutics Incorporated (PRLD)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/PRLD/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 4.58M | $ -10.39M | $ -21.69M | $ 17.72M | $ 60.18M |
| 2025 | $ 12.43M | $ -101.88M | $ -57.72M | $ 17.79M | $ 68.64M |
| 2024 | $ 7.36M | $ -133.67M | $ -108.95M | $ 18.03M | $ 131.46M |
| 2023 | $ 0 | $ -131.73M | $ -119.56M | $ 16.89M | $ 237.09M |
| 2022 | $ 0 | $ -128.96M | $ -96.91M | $ 1.83M | $ 195.44M |
| 2021 | $ 0 | $ -132.77M | $ -102.05M | $ 1.74M | $ 285.90M |
| 2020 | $ 0 | $ -72.52M | $ -59.62M | $ 0 | $ 212.18M |
| 2019 | $ 0 | $ -35.59M | $ -19.04M | $ 258.0K | $ -49.41M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.29 |
| Liabilities / Eq | 0.99 |
| Current Ratio | 2.03 |

## Other views

- [Metrics](https://sponda.capital/en/PRLD.md)
- [Charts](https://sponda.capital/en/PRLD/charts.md)
- [Compare](https://sponda.capital/en/PRLD/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-13.